Session U: It is Not Always Just About HCV: Drug User Health and HCV
Tracks
.
| Friday, September 21, 2018 |
| 1:45 PM - 2:45 PM |
| Sala I |
Speaker
Dr Brendan Jacka
Postdoctoral Research Fellow
CHUM Research Centre
Sex, Drugs And HCV: The Role Of Sex And Sex Work In Hepatitis C Virus Infection Among People Who Inject Drugs In Montreal
1:45 PM - 2:00 PMBiography
With a background in research and diagnostic laboratories in the blood borne virus field, Brendan is expanding his research skills to include epidemiology of infectious diseases and substance misuse in vulnerable populations.
Dr Magdalena Harris
Associate Professor
London School Of Hygiene & Tropical Medicine
Care Beyond The Virus: Engaging The Most Marginalised In Hepatitis C Care
2:00 PM - 2:15 PMBiography
Dr Magdalena Harris is an Associate Professor at the London School of Hygiene & Tropical Medicine. Her expertise lies in qualitative methods and the social sciences of hepatitis C and harm reduction.
Professor Margaret Hellard
Deputy Director Programs
Burnet Institute
Preliminary Analysis Of The Prime Study; A Randomized Controlled Trial Comparing The Hepatitis C Care Cascade In Primary Care Vs. Tertiary Care
2:15 PM - 2:30 PMBiography
Professor Hellard is an infectious diseases physician and Deputy Director of the Burnet Institute. She has extensive experience in population health research and clinical trials in Hepatitis C, particularly among people who inject drugs and gay and bisexual men.
Andreea Adelina Artenie
Phd Candidate
Université de Montréal
Changes In Drug And Alcohol Use And Injection Risk Behaviours Among People Who Inject Drugs During And Following HCV Direct-Acting Antiviral Treatment: The Simplify And D3feat Studies
2:30 PM - 2:35 PMBiography
Adelina Artenie is a PhD candidate in Public Health, Epidemiology at Université de Montréal.
Mr. Prof. Dr. med. Jens Reimer
Geschäftsführender Direktor
Universitätssklinikum Hamburg-Eppendorf
Real-World Data On Safety And Effectiveness Of Glecaprevir/Pibrentasvir For The Treatment Of Patients With Chronic Hepatitis C Virus Infection On Opioid Substitution Therapy: Latest Results From The German Hepatitis C-Registry
2:35 PM - 2:40 PMBiography
Prof. Dr. Jens Reimer is Executive Director, Center for Psychosocial Medicine, Gesundheit Nord – Bremen Hospital Group, Bremen, Germany, and Director of the Center for Interdisciplinary Addiction Research at the University of Hamburg.
Mr Ned Latham
MBBS(Hons)/BMedSc(Hons) student
Burnet Institute
Treatment Outcomes Achieved With All-Oral Hepatitis C Treatment In People Who Currently Inject Drugs: A Systematic Review And Meta-Analysis
2:40 PM - 2:45 PMBiography
Ned is a final year medical student at Monash University. In 2017, he completed an honours thesis at the Burnet Institute examining the acceptability of point-of-care hepatitis C testing at needle syringe programs. Ned’s other areas of interest include sexual health, patient safety, and consumer advocacy.
Chair
Suzanne Brissette
Physician, CHUM Addiction Services
CHUM
Kathryn Leafe
Executive Director
NZNEP
